Local News: Spring Lake, NC 

 | 

Sign Up

 | 

Sign In

Advertisment

Metformin (generic), Glucophage

Metformin (generic), Glucophage Wire

Comprehensive News Feed for Metformin (generic), Glucophage.

Results 1 - 20 of 486 in Metformin (generic), Glucophage

  1. Roche, Ipsen note positive results in diabetes drug trialRead the original story

    40 min ago | Drug Store News

    PARIS An investigational diabetes drug developed by Roche and Ipsen offers glycemic control comparable to that of an insulin produced by Sanofi-Aventis, according to results of two late-stage clinical trials announced Thursday.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Biotech, SanofiSynthlabo, Lantus, Insulin Glargine (generic)

  2. Roche, Ipsen note positive results in diabetes drug trialRead the original story

    10 hrs ago | Drug Store News

    PARIS An investigational diabetes drug developed by Roche and Ipsen offers glycemic control comparable to that of an insulin produced by Sanofi-Aventis, according to results of two late-stage clinical trials announced Thursday.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Biotech, SanofiSynthlabo, Lantus, Insulin Glargine (generic)

  3. Ipsen's partner Roche announces that Taspoglutide meets its primary...Read the original story

    23 hrs ago | Drugs.com

    Ipsen , an innovationdriven global specialty pharmaceutical group, today announced that its partner Roche has disclosed headline results of the fourth and fifth of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first once weekly glucagon-like peptide-1 analogue based on a human sequence.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Lantus, Insulin Glargine (generic), Medication, Insulin (generic), Humulin, Novolin

  4. Roche, Ipsen Diabetes Drug Meets Goals in StudiesRead the original story

    Yesterday | BioSpace

    Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed headline results of the fourth and fifth of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first once weekly glucagon-like peptide-1 analogue based on a human sequence.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Lantus, Insulin Glargine (generic), Medication, Insulin (generic), Humulin, Novolin

  5. Ipsena s partner Roche announces that Taspoglutide meets its primary ...Read the original story

    Yesterday | Business Wire

    Ipsen , an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed headline results of the fourth and fifth of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first once weekly glucagon-like peptide-1 analogue based on a human sequence.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Lantus, Insulin Glargine (generic), Medication, Insulin (generic), Humulin, Novolin

  6. Clinical Trials Update: Dec. 15, 2009Read the original story

    Tuesday | HON

    Depression This study seeks people diagnosed with depression that have not fully responded to an antidepressant medication.

    Comment?

    Related Topix: Depression, Health, Menlo Park, CA, Medicine, Diabetes

  7. Positive results from study comparing exenatide once weekly to BYETTARead the original story

    Tuesday Dec 15 | Medical News

    Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTAA injection taken twice daily, in patients with type 2 diabetes .

    Comment?

    Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Eli Lilly, Alkermes, Diabetes, Health

  8. Santarus Announces Webcast Presentation at the Lippert/Heilshorn Life Sciences Virtual ConferenceRead the original story

    Monday Dec 14 | Freshnews

    Santarus, Inc. announces the following webcast: Date: Tuesday, December 15, 2009 Time: 10:30 a.m. Eastern time Speaker: Gerald T. Proehl, Santarus president and chief executive officer The webcast can be accessed by visiting the Investor Relations section of the company's Web site at www.santarus.com . The webcast presentation will be archived and ...

    Comment?

    Related Topix: Biotech, Healthcare Industry, Santarus

  9. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.Read the original story

    Monday Dec 14 | CiteULike

    RESEARCH DESIGN AND METHODS: This 28-week parallel-group study randomized 233 insulin-naive patients with HbA values>/=8.0% on>1,000 mg/day metformin alone or in combination with other OADs.

    Comment?

    Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Diabetes, Health, Lantus, Insulin Glargine (generic)

  10. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.Read the original story

    Monday Dec 14 | CiteULike

    METHODS: In an open-label, controlled, multicenter trial, we randomly assigned 708 patients with a suboptimal glycated hemoglobin level who were receiving maximally tolerated doses of metformin and sulfonylurea to receive biphasic insulin aspart twice daily, prandial insulin aspart three times daily, or basal insulin detemir once daily .

    Comment?

    Related Topix: Insulin (generic), Humulin, Novolin, Medicine, Medication, Health, Diabetes

  11. Initial Therapy For Type 2 DiabetesRead the original story

    May 28, 2009 | ADVANCE for Nurse Practitioners

    Healthcare providers can no longer use tradition or clinical experience alone to guide clinical care decisions.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Centers for Disease Control and Prevention, Medication, Nursing

  12. Tight ControlRead the original story

    Saturday Dec 12 | Diabetes Self Management

    A method of intensive diabetes self-management that involves keeping blood glucose levels as close as possible to normal without causing severe or frequent episodes of hypoglycemia , in the aim of preventing complications of diabetes.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Glyburide (generic), Micronase, Diabeta

  13. Health Brief: December 11Read the original story

    Friday Dec 11 | WBAY

    New research shows one class of diabetes drugs may increase patients' risk of heart problems.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Dymelor, Acetohexamide (generic), Medication, Glyburide (generic), Micronase, Diabeta, Amaryl, Glimepiride (generic)

  14. New Research Claims Diabetes Drug Has Higher Risk Of Heart DiseaseRead the original story

    Wednesday Dec 9 | Medical News Today

    Main Category: Diabetes Also Included In: Heart Disease ; Cardiovascular / Cardiology Article Date: 09 Dec 2009 - 19:00 PST New research claims that sulphonylureas, a class of drugs used to treat Type 2 diabetes , carry a greater risk of heart failure and death compared with the diabetes drug metformin.

    Comment?

    Related Topix: Medicine, Health, Diabetes, Medication

  15. Heart Disease And Diabetes: More Cutting Edge Science To Save Your LifeRead the original story

    Wednesday Dec 9 | Heart Info

    Few disease conditions are so thoroughly intertwined as coronary artery disease and diabetes.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Cardiology, Insulin (generic), Humulin, Novolin

  16. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetesRead the original story

    Tuesday Dec 8 | CiteULike

    Abstract Objective To evaluate systematically the review literature on type 2 diabetes to assess transmission of the findings of the United Kingdom prospective diabetes study , an important source of recent valid patient oriented evidence that matters .

    Comment?

    Related Topix: Medicine, Health, Diabetes, Medication

  17. More evidence that sulfonylureas are associated with increased mortality

    Tuesday Dec 8 | Notes from Dr. RW

    This isn't new. In fact I've mentioned it here and in multiple other posts, but Internal Medicine News now reports : Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients with a history of MI, according to a comprehensive Danish ...

    Comment?

    Related Topix: Medicine, Medication, Amaryl, Glimepiride (generic), Orinase, Tolbutamide (generic), Glucotrol, Glipizide (generic), Glyburide (generic), Micronase, Diabeta, Insulin (generic), Humulin, Novolin

  18. Scientists Develop Rice To Treat Atopic Dermatitis, DiabetesRead the original story

    Tuesday Dec 8 | Malaysian National News Agency

    A group of South Korean scientists has developed a new type of rice, which could help to treat atopic dermatitis and diabetes, two diseases that afflicting countless people around the world, reported Yonhap news agency on Tuesday.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Agriculture, Science

  19. Medical Minute: Diabetes DrugRead the original story

    Monday Dec 7 | WDIO

    It is a devilish paradox: diabetes patients face an increased risk for heart disease and death due to their blood sugar problems, but the medications to treat the blood sugar disorder may raise heart risk even more .

    Comment?

    Related Topix: Medicine, Diabetes, Health, Dymelor, Acetohexamide (generic)

  20. Metformin vs. Sulfonylureas for DiabetesRead the original story

    Friday Dec 4 | MedicineNet

    Dec. 4, 2009 -- Concerns that the diabetes drugs Avandia and Actos raise the risk for heart failure led the FDA to require label changes warning of the potential risk two years ago.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Medication, Actos, Pioglitazone (generic), Avandia, Rosiglitazone (generic), Dymelor, Acetohexamide (generic), Tolinase, Tolazamide (generic)